Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Journal of Cancer Research and Clinical Oncology|July 5, 2021
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysisPatrick Sven Plum, Alexander Damanakis, Lisa Buschmann, et al.
Frontiers in Oncology|August 9, 2021
Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer CenterAlexander Quaas, Jan Rehkaemper, Josef Rueschoff, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 19, 2021
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinomaAlexander Quaas, Aylin Pamuk, Sebastian Klein, et al.
Journal of Cancer Research and Clinical Oncology|December 30, 2017
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomachHarald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancerFlorian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Radiation Oncology (London, England)|April 4, 2024
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancerSimone Wegen, Karina Claus, Philipp Linde, et al.
Plos One|December 17, 2008
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET)Roland T Ullrich, Thomas Zander, Bernd Neumaier, et al.
British Journal of Cancer|November 1, 2018
Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancerLars Mortimer Schiffmann, Melanie Fritsch, Florian Gebauer, et al.
Oncoimmunology|July 29, 2016
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterationsAndreas H Scheel, Sascha Ansén, Anne M Schultheis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimusLucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Journal of Cancer Research and Clinical Oncology|July 5, 2021
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysisPatrick Sven Plum, Alexander Damanakis, Lisa Buschmann, et al.
Frontiers in Oncology|August 9, 2021
Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer CenterAlexander Quaas, Jan Rehkaemper, Josef Rueschoff, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 19, 2021
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinomaAlexander Quaas, Aylin Pamuk, Sebastian Klein, et al.
Journal of Cancer Research and Clinical Oncology|December 30, 2017
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomachHarald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancerFlorian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Radiation Oncology (London, England)|April 4, 2024
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancerSimone Wegen, Karina Claus, Philipp Linde, et al.
Plos One|December 17, 2008
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET)Roland T Ullrich, Thomas Zander, Bernd Neumaier, et al.
British Journal of Cancer|November 1, 2018
Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancerLars Mortimer Schiffmann, Melanie Fritsch, Florian Gebauer, et al.
Oncoimmunology|July 29, 2016
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterationsAndreas H Scheel, Sascha Ansén, Anne M Schultheis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimusLucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
Pageof 21